HRT and cardiovascular disease

Annals of the New York Academy of Sciences

Volumn 997, Issue , 2003, Pages 358-372

  Samsioe, Goran ^a  

^a LUND UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Cariovascular disease (CVD); Estrogen; Estrogen progestin combination; HERS trial; Hormone replacement therapy (HRT)

Indexed keywords

CONJUGATED ESTROGEN PLUS MEDROXYPROGESTERONE ACETATE; ESTROGEN; GESTAGEN; HORMONE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; DIET; DRUG EFFECT; FAMILY HISTORY; HEART PROTECTION; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; LIPID ANALYSIS; MENOPAUSE; MORBIDITY; MORTALITY; OBESITY; PHYSICAL ACTIVITY; RISK FACTOR; AGED; CONTROLLED CLINICAL TRIAL; CORONARY ARTERY DISEASE; ESTROGEN THERAPY; FEMALE; FOLLOW UP; METHODOLOGY; MIDDLE AGED; PHYSIOLOGY; POSTMENOPAUSE; PREVALENCE; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SWEDEN; TREATMENT OUTCOME;

ANIMALIA;

AGED; CARDIOVASCULAR DISEASES; CORONARY DISEASE; ESTROGEN REPLACEMENT THERAPY; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; PREVALENCE; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; SWEDEN; TREATMENT OUTCOME;

EID: 0642333860     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1196/annals.1290.039     Document Type: Conference Paper

References (22)

1. HULLEY, S., D. GRADY, T. BUSH, et al. 1998. Randomized trial of estrogen plus progestin for secondary prevention of coronary artery disease in post menopausal women. JAMA 280: 605-613.
2. LIDFELDT, J., C. NERBRAND, G. SAMSIOE, et al. 2001. A screening procedure detecting high-yield candidates for OGTT. The women's Health in the Lund area (WHILA) study: A population based study of middle-aged women. Eur. J. Epidemiol. 17: 943-951.
3. GRADY, D., D. HERRINGTON, V. BITNER, et al. 2002. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 288: 49-57.
4. HULLEY, S., C. FURBERG, E. BARRET-CONNOR, et al. 2002. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study Follow-up (HERS II). JAMA 288: 58-66.
5. WRITING GROUP FOR THE WOMEN'S HEALTH INITIATIVE INVESTIGATORS. 2002. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 288: 321-333.
6. PETITTI, D.B. 2002. Hormone replacement therapy for prevention. More evidence, more pessimism (Editorial). JAMA 288: 99-101.
7. STAMPFER, M.J., F.B. HU, J.E. MANSON, et al. 2000. Primary prevention of coronary heart disease in women through diet and lifestyle. N. Engl. J. Med. 343: 16-22.
8. HUMPHREY, L., CHAN, B. & H. SOX. 2002. Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease. Ann. Intern. Med. 137: 273-284.
9. NEVES-E-CASTRO, M., M. DOREN, G. SAMSIOE & S. SKOUBY. 2002. Results from WHI and HERS-II. Implications for women and the prescriber of HRT. Maturitas 9: 255.
10. CLARKE, S.C., J. KELLEHER, H. LLOYD-JONES, et al. 2002. A study of hormone replacement therapy in postmenopausal women with ischaemic heart disease: the Papworth HRT Atherosclerosis Study. Br. J. Obstet. Gynaecol. 109: 1056-1062.
11. th World Congress on the Menopause. Berlin.
12. MANSON, J.E., P. GREENLAND, A.Z. LACROIX, et al. 2002. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N. Engl. J. Med. 347: 755-756.
13. MOSCA, L., P. COLLINS, D.M. HERRINGTON, et al. 2001. Hormone replacement therapy and cardiovascular disease. A statement for healthcare professionals from the American Heart Association. Circulation 104: 499-503.
14. HERRINGTON, D.M., D.M. REBOUSSIN, K.B. BROSNIHAN, et al. 2000. Effects of estrogen replacement on the progression of coronary artery atherosclerosis. N. Engl. J. Med. 343: 522-529.
15. FIORETTI, F., A. TAVANI, S. GALLUS, et al. 2000. Menopause and risk of non-fatal acute myocardial infarction: an Italian case-control study and a review of the literature. Hum. Reprod. 15: 599-603.
16. SAMSIOE, G., M. NEVES-E-CASTRO, A. PINES, et al. 2001. Critical comments. Maturitas 40: 5-15.
17. HEMMINKI, E. & K. MCPHERSON. 1997. Impact of postmenopausal hormone therapy on cardiovascular disease and cancer; pooled data from clinical trials. BMJ 315: 149-153.
18. CORONARY DRUG PROJECT RESEARCH GROUP. 1973. The Coronary Drug Project; design, methods and baseline results. Circulation 47(Suppl. 3): 1-60.
19. BARRETT-CONNOR, E., D. GRADY, A. SASHEGYI, et al. 2002. Raloxifene and cardiovascular events in osteoporotic postmenopausal women. JAMA 287: 847-857.
20. PERE-GUTTHANN, S.P., L.G. RODRÍGUEZ, J. CASTELLSAGUE & A.D. OLIART. 1997. Hormone replacement therapy and risk of venous thrombo-embolism: population based case-control study. BMJ 314: 796-800.
21. GISSI INVESTIGATORS. 1999. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della sopraawivenza nell Infarto miocardico. Lancet 354: 447-455.
22. HODIS, H.N., W.J. MACK, R.A. LOBO, et al. 2001. Estrogen in the prevention of atherosclerosis. A randomised double-blind, placebo-controlled trial. Ann. Intern. Med. 135: 939-953.